BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
Spikes, Leslie A., Bajwa, Abubakr A., Burger, Charles D., Desai, Sapna V., Eggert, Michael S., El‐Kersh, Karim A., Fisher, Micah R., Johri, Shilpa, Joly, Joanna M., Mehta, Jinesh, Palevsky, Harold I., Ramani, Gautam V., Restrepo‐Jaramillo, Ricardo, Sahay, Sandeep, Shah, Trushil G., Deng, Chunqin, Miceli, Melissa, Smith, Peter, Shapiro, Shelley M.
Published in Pulmonary circulation (01.04.2022)
Published in Pulmonary circulation (01.04.2022)
Get full text
Journal Article
Plain language summary of the INCREASE study: inhaled treprostinil (Tyvaso) for the treatment of pulmonary hypertension due to interstitial lung disease
West, Natalie, Smoot, Karen, Patzlaff, Natalie, Miceli, Melissa, Waxman, Aaron
Published in Future cardiology (01.04.2023)
Published in Future cardiology (01.04.2023)
Get full text
Journal Article